US 8716338
Dosage units of 3-(6-(1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
granted A61KA61K31/443A61K31/47
Quick answer
US patent 8716338 (Dosage units of 3-(6-(1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid) held by Vertex Pharmaceuticals Incorporated expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 58
- CPC classes
- A61K, A61K31/443, A61K31/47, A61K45/06, A61K9/2018